Humphreys, M.M
What works great for one person might not be the best for another
In the STEP trials, semaglutide 2.4mg weekly resulted in mean weight reductions of 1517% over 68 weeks, whilst tirzepatide in the SURPASS trials showed reductions of 1520% (Kushner et al
P values were determined by 2 tailed independent-samples t test, 1-way ANOVA with Bonferroni, Dunnett T3, Tukey HSD, and LSD posthoc tests, and 2-way repeated measures
El riesgo silencioso: Qu estamos perdiendo realmente
A year later, a study that recruited 130 patients that had been clinically diagnosed with Alzheimers disease found that yearlong treatment with acetyl l-carnitine reduced the deterioration of cognitive ability in 13 out of 14 measurements, with 6 of these being classed as significant